cobaltous chloride has been researched along with mocetinostat in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Lei, T; Li, F; Luo, D; Wang, W; Yang, B; Zhang, Q; Zhou, H | 1 |
1 other study(ies) available for cobaltous chloride and mocetinostat
Article | Year |
---|---|
Low molecular weight fucoidan against renal ischemia-reperfusion injury via inhibition of the MAPK signaling pathway.
Topics: Acute Kidney Injury; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Cell Line; Cell Survival; Cobalt; Cytochromes c; Humans; Male; Malondialdehyde; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Molecular Weight; Peroxidase; Phosphorylation; Polysaccharides; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury; Superoxide Dismutase; Tumor Suppressor Protein p53 | 2013 |